SCHEMBL5814720

SCHEMBL5814720

Cc1[nH]c(-c2n[nH]cc2NC(=O)c2c(F)cc(F)cc2F)nc1C(F)(F)F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.42
NPSR1 Q6W5P4 5/20 0.39
GAA P10253 4/20 0.38
CYP1A2 P05177 3/20 0.38
CYP3A4 P08684 3/20 0.38
CYP2C19 P33261 3/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C9 P11712 2/20 0.38
HPGD P15428 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
CDK2 P24941 2/20 0.33
CCNA2 P20248 1/20 0.33
HTR1F P30939 2/20 0.32
POLB P06746 2/20 0.32
CHRM5 P08912 1/20 0.32
DRD5 P21918 1/20 0.32
HTR1D P28221 1/20 0.32
HTR1E P28566 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5811804 0.83 TLR7 (0.43) LMNANPSR1GAARAB9AALDH1A1
SCHEMBL5578091 0.82 ABL1 (0.44) LMNANPSR1GAACYP1A2CYP3A4
SCHEMBL5814198 0.81 SCN8A (0.40) LMNANPSR1CYP1A2CYP3A4CYP2C19
SCHEMBL5105859 0.78 CCNA2 (0.38) CDK2CCNA2HTR1FCHRM5DRD5
SCHEMBL5578113 0.76 MEN1 (0.43) LMNANPSR1GAACYP1A2CYP3A4
SCHEMBL14511716 0.76 KCNMA1 (0.48) LMNAHPGDSMN1; SMN2NPC1RAB9A
SCHEMBL8305475 0.76 MAPT (0.53) LMNANPSR1GAACYP1A2CYP3A4
SCHEMBL5102502 0.75 HTR1F (0.43) CYP1A2CYP2C19CYP2C9CDK2CCNA2
SCHEMBL5813580 0.75 CSNK1D (0.35) GAASMN1; SMN2NPC1RAB9APOLB
SCHEMBL5578253 0.75 MEN1 (0.40) LMNANPSR1GAACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006070202-A1 PYRAZOLE DERIVATIVES HAVING KINASE MODULATING ACTIVITY ASTEX THERAPEUTICS LIMITED (GB) 2006-07-06 WO disclosed